Annual Accounts Payable
$2.04 M
-$6.21 M-75.27%
December 31, 2024
Summary
- As of March 10, 2025, KNSA annual accounts payable is $2.04 million, with the most recent change of -$6.21 million (-75.27%) on December 31, 2024.
- During the last 3 years, KNSA annual accounts payable has risen by +$171.00 thousand (+9.15%).
- KNSA annual accounts payable is now -81.32% below its all-time high of $10.92 million, reached on December 31, 2018.
Performance
KNSA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.04 M
-$6.29 M-75.52%
December 31, 2024
Summary
- As of March 10, 2025, KNSA quarterly accounts payable is $2.04 million, with the most recent change of -$6.29 million (-75.52%) on December 31, 2024.
- Over the past year, KNSA quarterly accounts payable has stayed the same.
- KNSA quarterly accounts payable is now -81.32% below its all-time high of $10.92 million, reached on December 31, 2018.
Performance
KNSA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
KNSA Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -75.3% | 0.0% |
3 y3 years | +9.2% | +9.2% |
5 y5 years | -64.2% | -64.2% |
KNSA Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -75.3% | +9.2% | -75.5% | +214.7% |
5 y | 5-year | -75.3% | +305.4% | -75.5% | +305.4% |
alltime | all time | -81.3% | +861.8% | -81.3% | +305.4% |
Kiniksa Pharmaceuticals Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $2.04 M(-75.3%) | $2.04 M(-75.5%) |
Sep 2024 | - | $8.33 M(+12.6%) |
Jun 2024 | - | $7.39 M(+31.3%) |
Mar 2024 | - | $5.63 M(-31.7%) |
Dec 2023 | $8.25 M(+4.4%) | $8.25 M(+714.8%) |
Sep 2023 | - | $1.01 M(+56.2%) |
Jun 2023 | - | $648.00 K(-53.4%) |
Mar 2023 | - | $1.39 M(-82.4%) |
Dec 2022 | $7.90 M(+322.9%) | $7.90 M(+437.7%) |
Sep 2022 | - | $1.47 M(-41.8%) |
Jun 2022 | - | $2.52 M(-25.5%) |
Mar 2022 | - | $3.38 M(+81.1%) |
Dec 2021 | $1.87 M | $1.87 M(+13.3%) |
Sep 2021 | - | $1.65 M(-60.3%) |
Jun 2021 | - | $4.16 M(+50.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $2.76 M(+449.3%) |
Dec 2020 | $503.00 K(-91.2%) | $503.00 K(-87.2%) |
Sep 2020 | - | $3.92 M(+65.4%) |
Jun 2020 | - | $2.37 M(-44.5%) |
Mar 2020 | - | $4.27 M(-24.9%) |
Dec 2019 | $5.69 M(-47.9%) | $5.69 M(-11.6%) |
Sep 2019 | - | $6.44 M(-31.0%) |
Jun 2019 | - | $9.34 M(+35.5%) |
Mar 2019 | - | $6.89 M(-36.9%) |
Dec 2018 | $10.92 M(+796.4%) | $10.92 M(+133.9%) |
Sep 2018 | - | $4.67 M(+732.1%) |
Jun 2018 | - | $561.00 K(-79.9%) |
Mar 2018 | - | $2.80 M(+129.6%) |
Dec 2017 | $1.22 M(+474.5%) | $1.22 M |
Dec 2016 | $212.00 K | - |
FAQ
- What is Kiniksa Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual accounts payable year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly accounts payable year-on-year change?
What is Kiniksa Pharmaceuticals annual accounts payable?
The current annual accounts payable of KNSA is $2.04 M
What is the all time high annual accounts payable for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual accounts payable is $10.92 M
What is Kiniksa Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, KNSA annual accounts payable has changed by -$6.21 M (-75.27%)
What is Kiniksa Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of KNSA is $2.04 M
What is the all time high quarterly accounts payable for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly accounts payable is $10.92 M
What is Kiniksa Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, KNSA quarterly accounts payable has changed by $0.00 (0.00%)